Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease is a research paper published in New England Journal of Medicine (2025). On theSindex it has a DataRank of 0. It has been cited 294 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Heart, Lung, and Blood Institute
Grant: P01HL142494
National Heart, Lung, and Blood Institute
Grant: R35HL145203
National Center for Advancing Translational Sciences
Grant: U01TR005355
National Center for Advancing Translational Sciences
Grant: DP2CA281401
Children’s Hospital of Philadelphia
Grant: CHOP Research Institute Frontier Programs
National Institute of Neurological Disorders and Stroke
Grant: U19NS132301
National Institute of Neurological Disorders and Stroke
Grant: U19NS132303
Acuitas Therapeutics
Aldevron
Integrated DNA Technologies
Danaher
FWCI
127.61
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords